Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bolus vs Continuous Remimazolam for Induction in Elderly
NCT05538741Completed
- Sponsor
- Kangbuk Samsung Hospital
- Start
- Jul 2023
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of remimazolam in general anesthesia (2 arms), sponsored by Kangbuk Samsung Hospital. Primary endpoint: The incidence of hypotension. Started Jul 2023; status: completed.
02
Drugs
remimazolam
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT05538741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05538741.